CDKN2A and glioblastoma: Progression to anaplastic oligodendroglioma is associated with additional genetic changes, such as loss of chromosome 9p, resulting in deletion of the CDKN2A tumor suppressor gene and the same TERT promoter mutations detected in glioblastoma [6].